The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement that Eli …
Eli Lilly and Co
Medicare will start covering obesity drugs for the first time. Here’s what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity …
Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness
A cruise ship outbreak of hantavirus has rattled the public and reignited fears of another global health scare as passengers …
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Pharma thinks it’s found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the drugmakers …
Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list
The CNBC Investing Club held its April Monthly Meeting on Thursday, with Jim Cramer and Jeff Marks, director of portfolio …
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on …
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t …
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized …
Here’s an update on our 4th Industrial Revolution stocks and the rest of the portfolio
On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran …
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the …